Skip to main content
. 2024 Jan 17;25:23. doi: 10.1186/s12882-024-03463-8

Table 3.

Cox regression simplified model (excluding living in rental block) eGFR hazard ratios for all-cause and CVD mortality among patients with type 2 diabetes stratified by age using 65 years as cut-off and gender, with eGFR between 90 and 119 mL/min per 1.73 m2 as reference (N = 36,556; years 2013–2019)

eGFR categories (mL/min per 1.73 m2) < 65 years ≥65 years
Male Female Male Female
All-cause mortality
 < 30 4.97 (1.23, 20.04) 18.22 (7.49, 44.32) 3.26 (2.22, 4.78) 5.73 (4.05, 8.10)
 30 - < 60 1.29 (0.79, 2.13) 2.75 (1.68, 4.51) 1.88 (1.55, 2.28) 2.63 (2.14, 3.22)
 60 - < 90 1.12 (0.88, 1.43) 1.64 (1.19, 2.25) 1.17 (0.98, 1.40) 1.92 (1.59, 2.32)
 90 - < 120 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)
CVD mortality
 < 30 6.11 (0.84, 44.20) 40.63 (13.09, 126.15) 2.80 (1.35, 5.84) 10.02 (5.44, 18.46)
 30 - < 60 1.51 (0.72, 3.16) 4.03 (1.76, 9.22) 1.87 (1.27, 2.74) 3.87 (2.51, 5.97)
 60 - < 90 1.09 (0.73, 1.65) 1.50 (0.77, 2.95) 1.19 (0.83, 1.72) 2.22 (1.46, 3.37)
 90 - < 120 1.00 (Reference) 1.00 (Reference) 1.00 (Reference) 1.00 (Reference)

Model: Elapsed time to all-cause/CVD mortality = eGFR + age + gender + eGFR*age + eGFR*gender + age*gender + eGFR*age*gender + covariates. Covariates: ethnicity, smoking, body mass index, lipid medications, established CVD, albuminuria. Abbreviations: eGFR estimated glomerular filtration rate, CVD cardiovascular disease